In conclusion, BC in women younger than 40 years have unfavorable clinicopathologiccharacteristics, and are more likely to be luminal B (HER2–), and less likely to bethe luminal A than BCs in women older than 40 years. The gene discussed is ERBB2; the disease is breast cancer.